Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
BrightInsight and CSL Behring announced a global digital health partnership to provide digitally-enhanced treatment experiences and regulated digital health offerings to support CSL Behring therapies.
read more
Aleafia Health’s indirect subsidiary, Emblem Germany GmbH, has formally submitted its application to German regulators for EU Good Manufacturing Practices (EU-GMP) certification.
read more
AI VIVO is seeking pharma and biotech collaboration partners to progress therapeutic candidates that have been identified by the Company as “top-ranked” for COVID-19.
read more
Humanigen has dosed the first COVID-19 patient in its study for lenzilumab, the company’s GM-CSF monoclonal antibody.
read more
Aidoc announced the FDA has allowed the use of their cleared AI algorithms intended for adjunctive use in the detection of findings associated with COVID-19.
read more
Fortress Biotech announced Oncogenuity has an agreement with Columbia University to develop novel oligonucleotides for the treatment of genetically driven cancers.
read more
ARTMS and Telix have entered into a development collaboration agreement to employ ARTMS’ high activity production of Gallium-68 for Telix’s prostate cancer imaging product TLX591-CDx for imaging of prostate cancer with PET.
read more
Group announced it is shipping Affimer reagents for COVID-19 antigen testing to its diagnostic test development partners.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Integra Pharma Solutions has formally withdrawn its EUA application in connection with its partner’s manufacture of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit from consideration in response to FDA guidance.
read more
Mologic and BioSure are working together to produce a COVID-19 antibody self-test.
read more
In response to scammers on the internet selling unproven medical products, the FDA has taken a number of steps to find and stop those selling unapproved products that fraudulently claim to mitigate, prevent, treat, diagnose or cure COVID-19.
read more
HCATS and apceth Biopharma have expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies.
read more
Yourway and Firma Clinical Research are joining to provide coordinated supply and product deliveries and administration services for virtual/decentralized clinical trials.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more